Bayesian Capital Management LP Purchases New Stake in Delek US Holdings, Inc. (NYSE:DK)

Bayesian Capital Management LP bought a new position in Delek US Holdings, Inc. (NYSE:DK - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund bought 21,090 shares of the oil and gas company's stock, valued at approximately $390,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Ameriprise Financial Inc. increased its stake in shares of Delek US by 14.4% in the 4th quarter. Ameriprise Financial Inc. now owns 792,111 shares of the oil and gas company's stock worth $14,654,000 after purchasing an additional 99,521 shares in the last quarter. Mercer Global Advisors Inc. ADV purchased a new stake in Delek US in the fourth quarter worth about $532,000. Freestone Grove Partners LP bought a new position in shares of Delek US in the fourth quarter worth about $209,000. Ion Asset Management Ltd. lifted its position in shares of Delek US by 16.5% during the 4th quarter. Ion Asset Management Ltd. now owns 3,455,000 shares of the oil and gas company's stock valued at $63,918,000 after buying an additional 488,509 shares in the last quarter. Finally, Northern Trust Corp increased its holdings in Delek US by 8.0% in the 4th quarter. Northern Trust Corp now owns 903,840 shares of the oil and gas company's stock worth $16,721,000 after acquiring an additional 66,815 shares in the last quarter. 97.01% of the stock is owned by institutional investors.

Delek US Trading Up 0.5 %

DK stock traded up $0.07 during midday trading on Friday, reaching $15.34. 2,235,558 shares of the company traded hands, compared to its average volume of 1,245,053. The firm has a market capitalization of $931.55 million, a price-to-earnings ratio of -3.16 and a beta of 0.74. The company has a debt-to-equity ratio of 3.18, a quick ratio of 0.67 and a current ratio of 1.04. The business has a 50 day moving average of $14.10 and a 200-day moving average of $16.61. Delek US Holdings, Inc. has a 52-week low of $11.03 and a 52-week high of $28.91.

Delek US (NYSE:DK - Get Free Report) last issued its earnings results on Wednesday, May 7th. The oil and gas company reported ($2.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.27) by ($0.05). Delek US had a negative return on equity of 28.21% and a negative net margin of 2.27%. The business had revenue of $2.64 billion for the quarter, compared to the consensus estimate of $2.56 billion. During the same quarter in the previous year, the company earned ($0.41) earnings per share. The firm's revenue was down 18.1% on a year-over-year basis. As a group, sell-side analysts expect that Delek US Holdings, Inc. will post -5.5 earnings per share for the current fiscal year.

Delek US Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, May 19th. Shareholders of record on Monday, May 12th will be issued a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 6.65%. The ex-dividend date is Monday, May 12th. Delek US's dividend payout ratio is currently -9.18%.

Insider Transactions at Delek US

In other news, CFO Mark Wayne Hobbs purchased 2,800 shares of the stock in a transaction on Tuesday, March 11th. The stock was bought at an average price of $13.70 per share, with a total value of $38,360.00. Following the transaction, the chief financial officer now owns 49,138 shares in the company, valued at $673,190.60. The trade was a 6.04 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last three months, insiders have acquired 5,055 shares of company stock valued at $70,787. Corporate insiders own 1.80% of the company's stock.

Analysts Set New Price Targets

DK has been the subject of a number of analyst reports. Scotiabank reduced their price objective on shares of Delek US from $24.00 to $14.00 and set a "sector perform" rating for the company in a research note on Friday, April 11th. Piper Sandler decreased their price target on Delek US from $18.00 to $17.00 and set a "neutral" rating on the stock in a report on Friday, March 7th. UBS Group dropped their price objective on Delek US from $21.00 to $13.25 and set a "neutral" rating for the company in a research note on Wednesday, April 9th. Raymond James decreased their target price on Delek US from $24.00 to $23.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Finally, Wells Fargo & Company dropped their price target on Delek US from $16.00 to $11.00 and set an "underweight" rating for the company in a research note on Wednesday, April 16th. Five investment analysts have rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $16.94.

About Delek US

Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.